Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis

Brian Lipworth (Lead / Corresponding author), Rory Chan, Chris Kuo

Research output: Contribution to journal › Letter › peer-review

Original language	English
Number of pages	1
Journal	Journal of Allergy and Clinical Immunology
DOIs	https://doi.org/10.1016/j.jaci.2020.09.024
Publication status	E-pub ahead of print - 5 Nov 2020

Access to Document

@article{105549ce2e50459593c8bef9ec26e403,

title = "Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis",

author = "Brian Lipworth and Rory Chan and Chris Kuo",

year = "2020",

month = nov,

day = "5",

doi = "10.1016/j.jaci.2020.09.024",

language = "English",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

}

TY - JOUR

T1 - Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis

AU - Lipworth, Brian

AU - Chan, Rory

AU - Kuo, Chris

PY - 2020/11/5

Y1 - 2020/11/5

U2 - 10.1016/j.jaci.2020.09.024

DO - 10.1016/j.jaci.2020.09.024

M3 - Letter

C2 - 33160644

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

ER -